Thomas F Dejgaard Selected Research

Thomas F Dejgaard Research Topics

11	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 12/2015
6	Body Weight (Weight, Body) 01/2022 - 12/2015
5	Overweight 09/2022 - 01/2017
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 04/2019
1	Bone Resorption 01/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Ketosis 12/2021
1	Prediabetic State (Prediabetes) 01/2021
1	Necrosis 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Nausea 01/2020

10	Insulin (Novolin)FDA Link 01/2022 - 12/2015
6	Liraglutide FDA Link 01/2022 - 12/2015
5	Glucose (Dextrose)FDA LinkGeneric 09/2022 - 01/2020
5	Glucagon-Like Peptide-1 ReceptorIBA 01/2022 - 01/2017
4	Exenatide (Byetta)FDA Link 01/2022 - 04/2019
1	Glucagon-Like Peptide 1 (GLP 1)IBA 09/2022
1	Procollagen Type IIBA 01/2022
1	SugarsIBA 01/2022
1	Collagen Type I (Type I Collagen)IBA 01/2022
1	Glucagon (Glukagon)FDA Link 11/2021
1	C-PeptideIBA 11/2021
1	Peptides (Polypeptides)IBA 11/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	dapagliflozinIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	8-Hydroxy-2'-DeoxyguanosineIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020
1	8-hydroxyguanosineIBA 01/2020
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2020
1	Interleukin-2 (IL2)IBA 01/2020
1	C-Reactive ProteinIBA 01/2020